161 related articles for article (PubMed ID: 12065057)
1. Radioprotection, pharmacokinetic and behavioural studies in mouse implanted with biodegradable drug (amifostine) pellets.
Srinivasan V; Pendergrass JA; Kumar KS; Landauer MR; Seed TM
Int J Radiat Biol; 2002 Jun; 78(6):535-43. PubMed ID: 12065057
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of early radiation effects in oral mucosa (mouse) by intravenous or subcutaneous administration of amifostine.
Fleischer G; Dörr W
Strahlenther Onkol; 2006 Oct; 182(10):567-75. PubMed ID: 17013569
[TBL] [Abstract][Full Text] [Related]
3. Behavioral toxicity and efficacy of WR-2721 as a radioprotectant.
Bogo V; Jacobs AJ; Weiss JF
Radiat Res; 1985 Nov; 104(2 Pt 1):182-90. PubMed ID: 3001816
[TBL] [Abstract][Full Text] [Related]
4. Radioprotection in mice following oral delivery of amifostine nanoparticles.
Pamujula S; Kishore V; Rider B; Fermin CD; Graves RA; Agrawal KC; Mandal TK
Int J Radiat Biol; 2005 Mar; 81(3):251-7. PubMed ID: 16019934
[TBL] [Abstract][Full Text] [Related]
5. A new orally active, aminothiol radioprotector-free of nausea and hypotension side effects at its highest radioprotective doses.
Soref CM; Hacker TA; Fahl WE
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e701-7. PubMed ID: 22330992
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of biodegradable enteric microcapsules of amifostine for oral delivery.
A G; Ren L; Zhou Z; Lu D; Wang S
Int J Pharm; 2013 Sep; 453(2):441-7. PubMed ID: 23796837
[TBL] [Abstract][Full Text] [Related]
7. Effects of dose and schedule on the efficacy of ethyol: preclinical studies.
Cassatt DR; Fazenbaker CA; Kifle G; Bachy CM
Semin Oncol; 2003 Dec; 30(6 Suppl 18):31-9. PubMed ID: 14727238
[TBL] [Abstract][Full Text] [Related]
8. Genistein treatment protects mice from ionizing radiation injury.
Landauer MR; Srinivasan V; Seed TM
J Appl Toxicol; 2003; 23(6):379-85. PubMed ID: 14635262
[TBL] [Abstract][Full Text] [Related]
9. Evaluation and optimization of radioprotective activity of Coronopus didymus Linn. in gamma-irradiated mice.
Prabhakar KR; Veerapur VP; Parihar KV; Priyadarsini KI; Rao BS; Unnikrishnan MK
Int J Radiat Biol; 2006 Aug; 82(8):525-36. PubMed ID: 16966180
[TBL] [Abstract][Full Text] [Related]
10. The rat acute-phase protein α2-macroglobulin plays a central role in amifostine-mediated radioprotection.
Mirjana M; Goran P; Nevena G; Melita V; Svetlana D; Ilijana G; Desanka B
J Radiol Prot; 2010 Sep; 30(3):567-83. PubMed ID: 20826884
[TBL] [Abstract][Full Text] [Related]
11. Tissue-protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats.
Trajković S; Dobrić S; Jaćević V; Dragojević-Simić V; Milovanović Z; Dordević A
Colloids Surf B Biointerfaces; 2007 Jul; 58(1):39-43. PubMed ID: 17317115
[TBL] [Abstract][Full Text] [Related]
12. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.
Ozsahin M; Betz M; Matzinger O; Bron L; Luthi F; Pasche P; Azria D; Mirimanoff RO; Zouhair A
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):141-5. PubMed ID: 16490870
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
Law A; Kennedy T; Pellitteri P; Wood C; Christie D; Yumen O
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1361-8. PubMed ID: 17869022
[TBL] [Abstract][Full Text] [Related]
14. Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy.
Cassatt DR; Fazenbaker CA; Bachy CM; Hanson MS
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):97-102. PubMed ID: 11917293
[TBL] [Abstract][Full Text] [Related]
15. Radioprotection by vitamin E: injectable vitamin E administered alone or with WR-3689 enhances survival of irradiated mice.
Srinivasan V; Weiss JF
Int J Radiat Oncol Biol Phys; 1992; 23(4):841-5. PubMed ID: 1319980
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity.
Vujaskovic Z; Feng QF; Rabbani ZN; Samulski TV; Anscher MS; Brizel DM
Exp Lung Res; 2002; 28(7):577-90. PubMed ID: 12396250
[TBL] [Abstract][Full Text] [Related]
18. Narrow amifostine dose windows define radioprotection outcome, following fractionated whole-body irradiation of mice.
Zois CE; Giatromanolaki A; Sivridis E; Tokmakidis SP; Botaitis S; Simopoulos C; Kortsaris A; Koukourakis MI
In Vivo; 2011; 25(2):191-6. PubMed ID: 21471534
[TBL] [Abstract][Full Text] [Related]
19. Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage.
Liu W; Chen Q; Wu S; Xia X; Wu A; Cui F; Gu YP; Zhang X; Cao J
J Radiat Res; 2015 Mar; 56(2):278-86. PubMed ID: 25617317
[TBL] [Abstract][Full Text] [Related]
20. Systematic assessment of tolerance to pentobarbital by pellet implantation.
Ho IK
J Pharmacol Exp Ther; 1976 Jun; 197(3):479-87. PubMed ID: 932988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
